Nautilus Biotechnology, Inc. Interest Income (Expense), Nonoperating, Net
Nautilus Biotechnology, Inc. (NAUT) reported Interest Income (Expense), Nonoperating, Net of $1.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-07-28
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $1.31M, a 37.16% decline year-over-year.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $1.44M, a 35.37% decline year-over-year.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $1.65M, a 31.96% decline year-over-year.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $1.90M, a 28.83% decline year-over-year.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for fiscal 2025 was $7.87M, a 27.01% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for fiscal 2024 was $10.78M, a 14.10% decline from fiscal 2023.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for fiscal 2023 was $12.55M, a 115.78% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. interest income (expense), nonoperating, net for fiscal 2022 was $5.82M, a 1667.78% increase from fiscal 2021.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 9 month as first filed | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.31M 10-Q · filed 2026-07-28 | $2.75M 10-Q · filed 2026-07-28 | $4.40M derived: sum of 3 quarters · filed 2026-07-28 | $6.31M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2026-03-31 | $1.44M 10-Q · filed 2026-04-28 | $3.10M derived: sum of 2 quarters · filed 2026-04-28 | $5.00M derived: sum of 3 quarters · filed 2026-04-28 | $7.08M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.56M derived: sum of 2 quarters · filed 2026-02-26 | $5.64M derived: sum of 3 quarters · filed 2026-07-28 | $7.87M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.90M 10-Q · filed 2025-10-28 | $3.98M derived: sum of 2 quarters · filed 2026-07-28 | $6.21M 10-Q · filed 2025-10-28 | $8.64M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-06-30 | $2.08M 10-Q · filed 2026-07-28 | $4.31M 10-Q · filed 2026-07-28 | $6.74M derived: sum of 3 quarters · filed 2026-07-28 | $9.42M derived: sum of 4 quarters · filed 2026-07-28 | |
| 2025-03-31 | $2.23M 10-Q · filed 2026-04-28 | $4.66M derived: sum of 2 quarters · filed 2026-04-28 | $7.34M derived: sum of 3 quarters · filed 2026-04-28 | $10.13M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.11M derived: sum of 2 quarters · filed 2026-02-26 | $7.90M derived: sum of 3 quarters · filed 2026-02-26 | $10.78M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.67M 10-Q · filed 2025-10-28 | $5.47M derived: sum of 2 quarters · filed 2025-10-28 | $8.35M 10-Q · filed 2025-10-28 | $11.38M derived: sum of 4 quarters · filed 2025-10-28 | |
| 2024-06-30 | $2.80M 10-Q · filed 2025-07-31 | $5.67M 10-Q · filed 2025-07-31 | $8.71M derived: sum of 3 quarters · filed 2025-07-31 | $11.90M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $2.88M 10-Q · filed 2025-04-29 | $5.91M derived: sum of 2 quarters · filed 2025-04-29 | $9.11M derived: sum of 3 quarters · filed 2025-04-29 | $12.33M derived: sum of 4 quarters · filed 2025-04-29 | |
| 2023-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.23M derived: sum of 2 quarters · filed 2025-02-27 | $9.45M derived: sum of 3 quarters · filed 2025-02-27 | $12.55M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $3.20M 10-Q · filed 2024-10-29 | $6.42M derived: sum of 2 quarters · filed 2024-10-29 | $9.52M 10-Q · filed 2024-10-29 | $12.40M derived: sum of 4 quarters · filed 2024-10-29 | |
| 2023-06-30 | $3.22M 10-Q · filed 2024-07-30 | $6.32M 10-Q · filed 2024-07-30 | $9.21M derived: sum of 3 quarters · filed 2024-07-30 | $11.10M derived: sum of 4 quarters · filed 2024-07-30 | |
| 2023-03-31 | $3.10M 10-Q · filed 2024-04-30 | $5.99M derived: sum of 2 quarters · filed 2024-04-30 | $7.87M derived: sum of 3 quarters · filed 2024-04-30 | $8.65M derived: sum of 4 quarters · filed 2024-04-30 | |
| 2022-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.78M derived: sum of 2 quarters · filed 2024-02-28 | $5.55M derived: sum of 3 quarters · filed 2024-02-28 | $5.82M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $1.89M 10-Q · filed 2023-10-31 | $2.67M derived: sum of 2 quarters · filed 2023-10-31 | $2.93M 10-Q · filed 2023-10-31 | $2.93M 10-Q · filed 2022-11-01 | $3.09M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $776.00K 10-Q · filed 2023-08-02 | $1.04M 10-Q · filed 2023-08-02 | $1.20M derived: sum of 3 quarters · filed 2023-08-02 | $1.34M derived: sum of 4 quarters · filed 2023-08-02 | |
| 2022-03-31 | $264.00K 10-Q · filed 2023-05-02 | $425.00K derived: sum of 2 quarters · filed 2023-05-02 | $561.00K derived: sum of 3 quarters · filed 2023-05-02 | ||
| 2021-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $297.00K derived: sum of 2 quarters · filed 2023-02-23 | $329.00K 10-K · filed 2023-02-23 | ||
| 2021-09-30 | $136.00K 10-Q · filed 2022-11-01 | $168.00K 10-Q · filed 2022-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |